简介:
Overview
This article describes a method for stable labeling of patient-derived xenografts (PDXs) using lentiviral particles that express green-fluorescent protein and luciferase reporters. This technique enables tracking of PDX growth and detection of metastases through in vivo imaging systems.
Key Study Components
Area of Science
- Cancer Research
- Metastasis Models
- In Vivo Imaging
Background
- Patient-derived xenografts (PDXs) are vital for studying cancer.
- Understanding metastasis is crucial for cancer treatment.
- Current methods often require extensive histological analysis.
- This protocol aims to simplify tracking of PDXs.
Purpose of Study
- To introduce reporter genes stably in PDXs.
- To facilitate the study of experimental and spontaneous metastasis.
- To enhance the understanding of metastasis from PDXs.
Methods Used
- Use of lentiviral particles for gene transduction.
- Application of aseptic techniques during the procedure.
- In vivo imaging systems for tracking PDX growth.
- Demonstration by a post-doctoral researcher.
Main Results
- Successful stable labeling of PDXs achieved.
- Enhanced tracking of tumor growth and metastasis.
- Reduction in the need for post-mortem histological analysis.
- Protocol applicable to various cancer types.
Conclusions
- The method provides a reliable way to study PDXs.
- It facilitates real-time monitoring of cancer progression.
- This approach can lead to better understanding of metastasis.
What are patient-derived xenografts?
Patient-derived xenografts (PDXs) are tumor tissues from patients that are implanted into immunocompromised mice for cancer research.
How does the labeling method work?
The method uses lentiviral particles to introduce reporter genes that allow for tracking of tumor growth and metastasis.
What is the significance of using in vivo imaging?
In vivo imaging allows researchers to monitor tumor progression in real-time without the need for invasive procedures.
Who demonstrated the protocol?
The protocol was demonstrated by Jessica Finlay-Schultz, a post-doctoral researcher.
What are the advantages of this method?
The main advantages include stable labeling, real-time tracking, and reduced need for histological analysis.
Can this method be applied to other cancer types?
Yes, the protocol is applicable to various types of cancer beyond breast cancer.